next-best-action
(4)
Aktana
Aktana spent years turning pharma’s scattered customer data into a daily recommendation engine. Now, under PharmaForceIQ, its field intelligence is being stitched to digital orchestration in a bid to close one of life sciences’ most expensive gaps.
Tyler Boyd
Tyler Boyd is the CEO of Youtility, a behavioral decision science company that models the emotional drivers behind consumer choices and feeds banks and brands real-time next-best-action recommendations through APIs. A Columbia-trained financier who spent nearly two decades in private equity, investment banking, and corporate strategy, Boyd moved from Wall Street deal rooms to the marketing-science world at Purple Strategies before sourcing and steering the merger of US fintech Squeeze with UK technology firm Youtility. He now runs the combined company across London and Richmond, Virginia, where its software counts Santander UK, Virgin Money, and Monese among its partners and recently closed a $4.2M seed round.
Verix
Verix is a Santa Clara-based software company that builds Tovana, an AI-powered commercial optimization platform for pharmaceutical and life sciences companies. Tovana unifies fragmented commercial data - prescription records, lab results, demographics, and digital marketing signals - and layers predictive modeling, GenAI, and automation on top so brand and field teams can decide the next best action, find the right patients, target the right physicians, and forecast more accurately. Its no-code architecture and pre-built connectors let most deployments go live in 4-8 weeks, and the platform is used by global drugmakers including Bayer, Novartis, GSK, Roche, and Kyowa Kirin.
John Vitalie
John Vitalie is the CEO of Aktana, a San Francisco-based AI platform company that helps global life sciences organizations optimize commercial engagement with healthcare providers. A three-time software CEO with leadership stints at Salesforce, Oracle, and Siebel Systems, Vitalie brings a decade of pioneering AI in life sciences to a company building what it calls a Contextual Intelligence Engine - blending AI, human insight, and omnichannel orchestration to make every pharma sales interaction more timely and personalized. Recognized as one of the Top 25 Biotech CEOs of 2022 by the Healthcare Technology Report, he champions a philosophy that AI should augment human judgment, not replace it.